CQDM partners with Neurasic Therapeutics, HBHL and the Louise and Alan Edwards Foundation to fund a non-opioid pain treatment discovery

News & Events

Montréal – Québec – January 12, 2022 –CQDM is pleased to announce a grant for a collaboration between McGill University, Neurasic Therapeutics, McGill University’s Healthy Brains, Healthy Lives (HBHL) initiative and the Louise and Alan Edwards Foundation. This collaborative research project, driven by the leadership of Philippe Séguéla, a neuroscientist globally recognized as a pioneer in the identification of pain channel … Read More

CQDM is hiring: Controller !

Job offers, News & Events

ABOUT CQDM Since its creation, CQDM has raised nearly $190 million to fund the development of approximately 130 drugs addressing major health concerns, including cancer, and neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium with the socially responsible mission of funding the development of innovative tools and technologies that accelerate the development of safe and effective drugs that benefit all … Read More

CQDM is hiring: Administrative Coordinator !

Job offers, News & Events

ABOUT CQDM  Since its creation, CQDM has raised nearly $190 million to fund the development of approximately 130 drugs addressing major health concerns, including cancer, and neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium with the socially responsible mission of funding the development of innovative tools and technologies that accelerate the development of safe and effective drugs that benefit all … Read More